MitoQ Mitigates Radiation‐Induced Testicular Injury: Molecular Docking and Toxicity Implications
Journal of Biochemical and Molecular Toxicology · 2025-08 · 39 (8)
DOI: 10.1002/jbt.70447 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Biochemical and Molecular Toxicology, online erschienen am 12.08.2025. Verfasst von Ayman A Ibrahim und 2 weiteren Autor:innen. Beteiligte Einrichtung: Drug Radiation Research Department, National Center for Radiation Research and Technology (NCRRT), Egyptian Atomic Energy Authority (EAEA), Cairo, Eg…. Hauptthemen laut MEDLINE: Ubiquinone, Testis, Molecular Docking Simulation, Organophosphorus Compounds. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 79 Literaturangaben. Gefördert von: This study has not received any funds from agencies in the public, commercial, or not‑for‑profit sectors..
Abstract (Originalsprache)
This study assessed the possible mitigating effect of a mitochondrion‐targeted antioxidant (MitoQ) against gamma irradiation‐induced testicular damage. The rats were distributed into five groups. The first group served as a control, the second group received MitoQ (2 mg/kg/day; i.p.) for 7 days, the third group was exposed to gamma radiation (5 gray as a single dose), the fourth group received MitoQ prophylactically before irradiation, and the last group was exposed to gamma radiation and then treated with MitoQ. The rats were killed 7 days after irradiation. MitoQ replenished mitochondrial ROS, indicating its antioxidant effect. MitoQ inhibited the intrinsic apoptosis cascade via a reduction in Bax and alleviated Bcl‐2. MitoQ improved steroidogenesis, as verified by an increase in testosterone and upregulation of 3β‐HSD and 17β‐HSD expression, in addition to increasing complex I and succinate dehydrogenase activity. Likewise, sperm evaluation corroborated these findings. The acute toxicity profile of MitoQ was investigated in mice and was found to be 75 mg/kg body weight. Additionally, a molecular docking study of MitoQ showed a good fit to the active site of succinate dehydrogenase. In conclusion, this study introduces MitoQ as a new approach for the management of testicular damage triggered by gamma irradiation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Drug Radiation Research Department, National Center for Radiation Research and Technology (NCRRT), Egyptian Atomic Energy Authority (EAEA), Cairo, Egypt.
- Department of Chemistry and Chemical Biology, McMaster University, Hamilton, ON, Canada.
ORCID-Profile: Ayman A Ibrahim, Marwa G El-Gazzar, Heba M Karam
Förderung
- This study has not received any funds from agencies in the public, commercial, or not‑for‑profit sectors.
Zitieren
APA
Ibrahim, A. A., El-Gazzar, M. G., & Karam, H. M. (2025). MitoQ Mitigates Radiation‐Induced Testicular Injury: Molecular Docking and Toxicity Implications. Journal of Biochemical and Molecular Toxicology, 39(8). https://doi.org/10.1002/jbt.70447
Vancouver
Ibrahim AA, El-Gazzar MG, Karam HM. MitoQ Mitigates Radiation‐Induced Testicular Injury: Molecular Docking and Toxicity Implications. Journal of Biochemical and Molecular Toxicology. 2025;39(8). doi:10.1002/jbt.70447
BibTeX
@article{Ibrahim2025,
author = {Ibrahim, Ayman A and El-Gazzar, Marwa G and Karam, Heba M},
title = {MitoQ Mitigates Radiation‐Induced Testicular Injury: Molecular Docking and Toxicity Implications},
journal = {Journal of Biochemical and Molecular Toxicology},
year = {2025},
volume = {39},
number = {8},
doi = {10.1002/jbt.70447}
}
EUVIMED